Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00258791

Effects of Pretreatment With Ibuprofen in Post-Electroconvulsive Therapy (ECT) Headache

Effects of Pretreatment With Ibuprofen in Post- ECT Headache

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Norwegian University of Science and Technology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to determine whether ibuprofen reduces post-ECT headache or reduces its severity.

Detailed description

The aim of the study is to compare the severity of headache between patients who are receiving ibuprofen prior to ECT treatment with patients receiving placebo prior to ECT treatment. Patients will be randomly assigned to receive either 600 mg ibuprofen 90 min prior to treatment or placebo orally, blinded to patient, physician and treatment team. Patients will be asked about their headache with a visual analogue scale (VAS) 2 hours prior to and within 2 hours after treatment, 2-month, 6- month and 1 year follow-up \[5\].

Conditions

Interventions

TypeNameDescription
DRUGIbuprofen

Timeline

Start date
2012-01-01
Primary completion
2012-05-01
Completion
2012-05-01
First posted
2005-11-28
Last updated
2012-09-25

Source: ClinicalTrials.gov record NCT00258791. Inclusion in this directory is not an endorsement.